CAZymes-associated method to explore glycans that mitigate DSS-induced colitis via targeting Bacteroides cellulosilyticus

• Published in: International journal of biological macromolecules 2024-02, Vol.258, p.128694-128694, Article 128694
• Main Authors: Gao, Xiaoxiang, Xu, FuSheng, Li, Tangjun, Huang, Pan, Yu, Leilei, Tian, Fengwei, Zhao, Jianxin, Chen, Wei, Zhai, Qixiao
• Format: Article
• Language: English
• Subjects: arabinogalactans; Bacteroides; Bacteroides cellulosilyticus; coculture; Colitis; digestive system; fermentation; mice; Microbiota-directed glycan; microorganisms; remission
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2023.128694

Improving Bacteroides cellulosilyticus abundance is a feasible approach to treating inflammatory bowel disease (IBD). Although B. cellulosilyticus is responsive to dietary components, untargeted manipulation cannot focus on target microbe and lead to an increase in harmful bacteria in the microbiota. Breakthroughs in methods for regulating specific microbes, but the protocols are expensive, time-consuming, and difficult to follow. Glycans based on microbial-carbohydrate-active enzymes (CAZymes) would provide a potential solution. We propose a method based on CAZymes to explore polysaccharides that target specific gut microbes and alleviate diseases. The designed polysaccharides (Arabinogalactan, AG) enrich the abundance of B. cellulosilyticus in single-strain co-cultures, fermentation in vitro, and mouse models in vivo. Supplementation with AG relieved mice from colitis and clinical symptoms. We reveal that AG directly alters B. cellulosilyticus level and cooperative microbes, resulting in remission of colitis. Our glycan design pipeline is a promising way to improve disease through the targeted enhancement of specific microbes.